FIT-(BCMA+CD19)-CAR-T Cells in Recurrent/Refractory Autoimmune Diseases Patients.
- Status
- ENROLLING_BY_INVITATION
- Phase
- EARLY_PHASE1
Clinical Trials Related to Autoimmune Diseases
Related studies linked through entity extraction aliases.
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Cluster of Differentiation 19 (CD19)/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Refractory Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Study of AFN50 Injection in the Autoimmune Diseases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Exploratory Study on LNP-mRNA Drugs Targeting CD19/BCMA for the Treatment of Relapsed and Refractory Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
To Evaluate the Safety and Tolerability of STR-P004 for the Treatment of Immune-mediated Kidney Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease
- Status
- RECRUITING
- Phase
- NA
Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes
- Status
- RECRUITING
- Phase
- N/A
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
- Status
- RECRUITING
- Phase
- PHASE1
Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
- Status
- RECRUITING
- Phase
- N/A